Mobile

Multicenter randomized open-label three-arms controlled 12 months clinical proof of concept study to evaluate efficacy and safety of Ranibizumab alone or in combination with laser treatment vs. laser ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-005542-35

Multicenter randomized open-label three-arms controlled 12 months clinical proof of concept study to evaluate efficacy and safety of Ranibizumab alone or in combination with laser treatment vs. laser treatment alone in Proliferative Diabetic Retinopathy

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Change of area of neovascularizations as measured by Fluorescein Angiography at month 12 (difference to baseline value).

Critère d'inclusion

  • Proliferative Diabetic Retinopathy

Liens